tradingkey.logo
搜索

Artivion Inc

AORT
添加自选
23.869USD
+0.319+1.35%
收盘 07/02, 13:00美东报价延迟15分钟
1.16B总市值
93.02市盈率 TTM

Artivion Inc

23.869
+0.319+1.35%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.35%

5天

+8.35%

1月

+13.39%

6月

-47.67%

今年开始到现在

-47.67%

1年

-22.38%

关键数据
23.640今开
24.150最高
315.63K成交量
93.02市盈率 TTM
50.73市盈率动
--股息TTM
0.65%换手率
23.550昨收
23.310最低
5.17M成交额
亏损市盈率静
2.57市净率
0.00%股息率 TTM
1.40%ROA
48.25052周最高
0.44量比
-13.34M净利润
48.50M总股本
0.2566每股收益TTM
1.29Beta
3.14%ROE
19.16052周最低
3.57%振幅
64.85%毛利率
1.16B总市值
6.92回报/风险
2.21%风险率

TradingKey Artivion Inc股票评分

单位: USD 更新时间: 2026-07-01

操作建议

Artivion Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名17/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价42.00。中期看,股价处于下降通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Artivion Inc评分

相关信息

行业排名
17 / 204
全市场排名
70 / 4564
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Artivion Inc亮点

亮点风险
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
业绩高增长
公司营业收入稳步增长,连续3年增长24.67%
业绩转盈
公司业绩转盈,最新年度盈利美元
估值高估
公司最新PE估值91.78,处于3年历史高位
机构加仓
最新机构持股45.29M股,环比增加1.10%
查克·罗伊斯持仓
明星投资者查克·罗伊斯持仓,最新持仓市值684.09K
活跃度增加
近期活跃度增加,过去20天平均换手率1.13

分析师目标

根据 8 位分析师
买入
评级
42.000
目标均价
+86.92%
涨幅空间

Artivion Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Artivion Inc简介

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
公司代码AORT
公司Artivion Inc
CEOMackin (James Patrick)
网址https://artivion.com/

常见问题

Artivion Inc(AORT)的当前股价是多少?

Artivion Inc(AORT)的当前股价是 23.55。

Artivion Inc的股票代码是什么?

Artivion Inc的股票代码是AORT。

Artivion Inc股票的52周最高点是多少?

Artivion Inc股票的52周最高点是48.25。

Artivion Inc股票的52周最低点是多少?

Artivion Inc股票的52周最低点是19.16。

Artivion Inc的市值是多少?

Artivion Inc的市值是1.14B。

现在Artivion Inc(AORT)的股票是买入、持有还是卖出?

根据分析师评级,Artivion Inc(AORT)的总体评级为买入,目标价格为42.00。

Artivion Inc(AORT)股票的每股收益(EPS TTM)是多少

Artivion Inc(AORT)股票的每股收益(EPS TTM)是0.22。